James Newman Topper
Independent DirectorDr. James Newman Topper, also known as Jamie, M.D., Ph.D., is Director of Laguna Pharmaceuticals Inc. from February 17, 2015. He is Director at Immutrin Ltd since March 2026. Dr. Topper joined the Laguna Pharmaceuticals Inc. on February 17, 2015. Dr. Topper is Director of Merganser Biotech, Inc. from February 19, 2015. Dr. Topper joined the Merganser Biotech, Inc. on February 19, 2015. Dr. Topper served as Independent Director of Alpine Immune Sciences, Inc. from June 13, 2016 until May 2024. Dr. Topper joined the Alpine Immune Sciences, Inc. on June 13, 2016. Dr. Topper is Board Observer of Sojournix, Inc. from 2017. Dr. Topper is Director of Seraxis, Inc. Dr. Topper is Member of Scientific Advisory Board of Inipharm, Inc. Dr. Topper is Independent Director of Phathom Pharmaceuticals, Inc. from September 2022. Dr. Topper was Independent Director of Phathom Pharmaceuticals, Inc. from January 2018 to May 21, 2021. Dr. Topper is Director of Lassen Therapeutics 1, Inc. from January 2023. He served as Director at AnaptsyBio, Inc., a biotechnology company, from November 2007 to September 2023. Dr. Topper was Chairman of the Board of Lassen Therapeutics 1, Inc. until January 2023. Dr. Topper is Independent Non-Executive Director of NewAmsterdam Pharma Company N.V. from November 2022. Dr. Topper is Director of Seraxis Holdings, Inc. Dr. Topper is Director of Enlaza Therapeutics, Inc. Dr. Topper is Managing Partner of Frazier Life Sciences Management, LP. Dr. Topper is Managing Partner of Frazier Management, L.L.C. Dr. Topper joined the Frazier Management, L.L.C. in 2003. Dr. Topper focuses on Life Science; Biopharmaceutical. Dr. Topper was General Partner of Frazier Management, L.L.C. from 2005. Dr. Topper was Partner of Frazier Management, L.L.C. from August 2003 to 2005. Dr. Topper was Managing General Partner of Frazier Management, L.L.C. Dr. Topper is Independent Chairman of the Board of Attovia Therapeutics, Inc. since June 2023. Dr. Topper is Director of Diagonal Therapeutics, Inc. Dr. Topper is Director of Serum Detect, Inc. Dr. Topper was Head of the Cardiovascular Research and Development Franchise of Millennium Pharmaceuticals, Inc. Dr. Topper was employed at Millennium Pharmaceuticals, Inc. from 2002 to 2003. Dr. Topper was Director of Amunix Pharmaceuticals, Inc. Dr. Topper was Independent Director of Portola Pharmaceuticals, Inc. Dr. Topper was employed at Portola Pharmaceuticals, Inc. from March 2011 to December 11, 2013. Dr. Topper was Independent Director of Sierra Oncology, Inc. Dr. Topper was employed at Sierra Oncology, Inc. from April 2014 to April 10, 2017. Dr. Topper was Director of La Jolla Pharmaceutical Company. Dr. Topper was employed at La Jolla Pharmaceutical Company from 2005 to September 03, 2009. Dr. Topper was Independent Director of Amicus Therapeutics, Inc. Dr. Topper was employed at Amicus Therapeutics, Inc. from 2004 to June 10, 2015. Dr. Topper was Director of Nivalis Therapeutics, Inc. Dr. Topper joined the Nivalis Therapeutics, Inc. on July 24, 2017. Dr. Topper was Non-Executive Director of Silence Therapeutics plc. Dr. Topper was employed at Silence Therapeutics plc from January 05, 2010 to July 29, 2011. Dr. Topper was Independent Chairman of AnaptysBio, Inc. until September 15, 2023. Dr. Topper was employed at AnaptysBio, Inc. from November 2007 to March 2024. Dr. Topper was Executive Officer of COR Therapeutics, Inc. Dr. Topper was Chairman of Intradigm Corporation. Dr. Topper joined the Intradigm Corporation in May 2006. Dr. Topper was Director of Azelon Pharmaceuticals, Inc. Dr. Topper joined the Azelon Pharmaceuticals, Inc. in May 2005. Dr. Topper was Director of MacuSight, Inc. Dr. Topper was Director of Altiris Therapeutics, Inc. Dr. Topper was Executive Chairman of Calistoga Pharmaceuticals, Inc. Dr. Topper joined the Calistoga Pharmaceuticals, Inc. in 2006. Dr. Topper was Executive Chairman of Arête Therapeutics, Inc. Dr. Topper was Director of Alnara Pharmaceuticals, Inc. Dr. Topper joined the Alnara Pharmaceuticals, Inc. in 2008. Dr. Topper was Director of Incline Therapeutics, Inc. Dr. Topper was Director of Rempex Pharmaceuticals, Inc. Dr. Topper was Independent Director of Allena Pharmaceuticals, Inc. from September 2011 to June 03, 2021. Dr. Topper was employed at Allena Pharmaceuticals, Inc. until June 03, 2021. He was Director of Alpine Immune Sciences (sold to Vertex). Dr. Topper was Director of Alcresta Therapeutics, Inc. until 2019. Dr. Topper was employed at Alcresta Therapeutics, Inc. until 2019. Dr. Topper was Director of Millendo Therapeutics, Inc. until December 2018. Dr. Topper was employed at Millendo Therapeutics, Inc. until December 2018. Dr. Topper was Director of Semnur Pharmaceuticals, Inc. Dr. Topper was Director of Entasis Therapeutics Inc. from April 2016. Dr. Topper joined the Entasis Therapeutics Inc. on April 04, 2016. Dr. Topper was Independent Director of Aptinyx Inc. from May 2016 to May 20, 2020. Dr. Topper was employed at Aptinyx Inc. from May 2016 to May 20, 2020. Dr. Topper was Director of Entasis Therapeutics Holdings Inc. from March 2016 to June 2019. Dr. Topper was employed at Entasis Therapeutics Holdings Inc. until June 2019. Dr. Topper was Director of Entasis Therapeutics Limited from March 2016. Dr. Topper was CEO & Chairman of the Board of Frazier Lifesciences Acquisition Corporation. Dr. Topper joined the Frazier Lifesciences Acquisition Corporation in 2003. Dr. Topper has B.S. in Biology from University of Michigan, Ph.D. in Biophysics from Stanford University School of Medicine in 1991, M.D. in Biophysics from Stanford University School of Medicine.
Positions
- Company NamePhathom Pharmaceuticals, Inc.Stock CodePHATPositionIndependent DirectorColleagues
- SLSteven L. BastaCEO, President & Director
- MFMichael F. ColaIndependent chairman of the Board
- DADavid A. SocksCo-Founder
- ANAzmi NabulsiCo-Founder
- SNSanjeev NarulaChief Financial & Business Officer
- AMAnne Marie CookChief Legal Officer & Corporate Secretary
- HKHeidi Kunz FieldsIndependent Director
- APAsit ParikhIndependent Director
- Company NameAttovia Therapeutics, Inc.Stock CodeATTOPositionIndependent Chairman of the BoardColleagues
- TFTao FuCEO, President & Director
- JNJames Newman TopperIndependent Chairman of the Board
- PVPetter VeibyChief Scientific Officer
- HCHubert C. ChenChief Medical Officer
- SCSteven ChanChief Financial Officer
- HZHangjun ZhanChief Technology Officer
- MHMitchell H. GoldIndependent Director
- AJAngie J. YouIndependent Director
- JWJohn W. SmitherIndependent Director
